Key result
Polypharmacy in the elderly is linked to increased morbidity and mortality, requiring careful medication management.
Why the study?
Polypharmacy is a common problem and a known risk factor for morbidity and mortality in the elderly, but more research is needed on consequences of unnecessary drug use.
Population
People aged 60 years and above
Comparison
Polypharmacy versus appropriate medication use
Design
Review of literature from MEDLINE and International Pharmaceutical Abstracts
Authors
Loading...
Polypharmacy burden in elderly merits clinical review; leaves open causal factors and deprescribing efficacy for prospective trials.
Polypharmacy is a significant risk factor for morbidity and mortality in the elderly, highlighting the need for routine medication evaluation to prevent unnecessary drug use.
ABDULRAHEEM Ibraheem Shola (2015) conducted a review in Polypharmacy. Polypharmacy was evaluated. Polypharmacy is a common problem and a known risk factor for important morbidity and mortality in the elderly, requiring careful medication evaluation and control strategies by healthcare professionals.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: